Article citationsMore>>

Lämsä, V., Levonen, A., Sormunen, R., Yamamoto, M. and Hakkola, J. (2012) Heme and Heme Biosynthesis Intermediates Induce Heme Oxygenase-1 and Cytochrome P450 2A5, Enzymes with Putative Sequential Roles in Heme and Bilirubin Metabolism: Different Requirement for Transcription Factor Nuclear Factor Erythroid-Derived 2-Like 2. Toxicological Sciences, 130, 132-144.
https://doi.org/10.1093/toxsci/kfs237

has been cited by the following article:

• TITLE: Advances in Cytochrome P450 in Tumor Therapy

  AUTHORS: Junhua Ming, Qing Zhang

  KEYWORDS: Cytochrome P450, Mechanism, Targeted Drugs, Tumor Therapy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.13 No.8, August 12, 2025

  ABSTRACT: Cytochrome P450 (CYP450) is a family of heme proteins capable of self-oxidation and is a type of monooxygenase. It was first discovered in the microsomes of liver cells and is distributed throughout various tissues and organs in the body, primarily localized on the inner membranes of the endoplasmic reticulum and mitochondria. CYP450 is involved in the metabolism of various endogenous and exogenous carcinogens and plays a significant role in the metabolism of numerous anticancer drugs and the development of tumors such as lung cancer, thyroid cancer, colorectal cancer, and breast cancer. Therefore, the development of CYP450-related anticancer targeted drugs and their expression in tumors have become a hot topic. This review aims to focus on the progress and clinical translation challenges of CYP450 in tumors.